MCM
EXAS

Mazama Capital Management’s Exact Sciences EXAS Stock Holding History

Mazama Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,920
Closed -$34K – 269
2013
Q4 		$34K Hold
2,920
– – 0.02% 193
2013
Q3 		$34K Buy
+2,920
New +$37.5K 0.02% 177

Other funds holding EXAS

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Mazama Capital Management's EXAS Position: Q1 2014 in Review

Mazama Capital Management sold out of Exact Sciences (EXAS) in Q1 2014, closing a stake of 2,920 shares — an estimated $34K sold.

Mazama Capital Management first reported a position in EXAS in Q3 2013 and held it in 2 quarters. The position peaked at $34K in Q4 2013. 151 funds tracked by Wall St. Rank hold EXAS as of Q1 2014.

  • Mazama Capital Management reported no remaining Exact Sciences position as of Q1 2014 after selling out during the quarter.
  • Mazama Capital Management sold 2,920 Exact Sciences shares in Q1 2014, an estimated $34K.
  • Mazama Capital Management first reported a position in Exact Sciences in Q3 2013 and held it in 2 quarters.
  • Mazama Capital Management's Exact Sciences position peaked at $34K in Q4 2013.
  • 151 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2014.

Based on Mazama Capital Management's 13F filing for Q1 2014, filed 3 Apr 2014.